Concepedia

George McGarry

GM

Statistics

Publications

5

Citations

156

H-Index

5

Active since

1986

Affiliations

Merck Serono Ltd. (United Kingdom)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

NHS Lanarkshire

George McGarry is an author at Merck Serono Ltd. (United Kingdom) specializing in medicinal chemistry, enzyme inhibition, and pharmacy.

Publications per year

1986–2010

5

Publications

5

Discovery and SAR of Org 24598—A Selective Glycine Uptake Inhibitor

Angus R. Brown, Ian Carlyle, John R. Clark et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 96 citations · Full text

, , +10

Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors

Zoran Ranković, Jiaqiang Cai, Jennifer Kerr et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 25 citations · Full text

, , +13

2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors

Jiaqiang Cai, David Jonathan Bennett, Zoran Ranković et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 12 citations · Full text

, , +9

Antiarrhythmic activity of 17.beta.-aminoestratrienes. Comparison of 3-ols and 3-acetates with the corresponding 3-(3-amino-2-hydroxypropyl) ethers

John K. Campbell, R. T. LOGAN, Richard Marshall et al. · Journal of Medicinal Chemistry · 1986 · 12 citations

, , +8

Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: Improving selectivity over hERG

Zoran Ranković, Jiaqiang Cai, Jennifer Kerr et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 11 citations · Full text

, , +15

1–5 of 5